SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 
Home Editorial ethics For authors Current issue Archive Contacts

No6(5) 2022

Back to the issue


DOI 10.37219/2528-8253-2022-6-57

Lieta O, Koshel I
The state of the nasopharyngeal microbiome in healthy people and in patients with chronic nasopharyngitis   
Leta Oleksii
Ivano-Frankivsk National Medical University
Postgraduate student of the Department of Otorhinolaryngology with a course in head and neck surgery
Email: leta.aleksey@gmail.com
https://orcid.org/0000-0002-8761-7446

Koshel Ivanna V.
Ivano-Frankivsk National Medical University
Associate Professor at the Department of Internal Medicine and Family Medicine
Doctor of Medical Sciences
ORCID ID: https://orcid.org/0000-0002-5466-4537

Abstract

Topicality: The chronic nasopharyngitis (CNP) morbidity rate tends to increase in childhood and adenoid removal is one of the most common of all surgeries in children. The state of the nasopharyngeal microbiome plays the significant role in the development of inflammatory processes of nasopharynx and adenoid hypertrophy and it is considered that the great progress can be made through its correction in conservative treatment and prevention of recurrence after surgery. Traditional cultural studies which reflect only a small proportion of bacteria present in the nasopharynx cannot describe the real state of microbiome. Therefore, the study of its quantitative and qualitative composit ion is essent ial for justified treatment.
Aim: to examine the state of the nasopharyngeal microbiome in patients with CNP associated with EpsteinBarr virus and compare its characteristics with the severity of disease.
Material and methods: 20 healthy persons and 32 patients diagnosed with CNP associated with EpsteinBarr virus have been included in the study. The qualitative composition of nasopharyngeal microflora and its quantitative characteristics have been studied by determining t itres of colony-forming units (CFU). The findings have been compared with the features of the clinical course of disease.
Results: The healthy individuals of the control group have Lactobacillus spp. and Bifidobacterium spp., aerobic S. salivarius, which belong to commensal microorganisms, as the basis of the nasopharyngeal microbiome. There has been seen the preservation of the population level of commensal flora: lactobacilli, bifidobacteria, salivary streptococci and appearance of opportunistic flora (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Escherichia coli) in small titres in the patients with mild CNP. During the moderate/severe course, there has been observed a sharp decline in the population level of commensal flora and an increase in the titer of opportunistic flora to the population level of commensals. In severe cases, the preservation of
high titers of opportunistic flora, complete absence of commensal one and emergence of pathogenic microflora (Pneumococcus pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa and yeast-like fungi of the Candida type) can be seen. All patients have been observed the presence of microbiome disorders, regardless of its quantitative and qualitative changes, which are accompanied by hypertrophy of the pharyngeal tonsil.
Conclusions: Dysfunction of the microbiome, i.e. changes in the quantitative and qualitative composition of microorganisms in patients with CNP, is important in the course of disease. Minor changes that are determined by a reduced level of commensal flora are associated with the mild disease course. If there is a significant reduction in the levels of commensals and emergence of opportunistic flora, the moderate/severe disease course can be observed. The complete absence of commensal flora, high titers of opportunistic pathogens and emergence of pathogenic flora including Candida albicans are characterized by a severe disease course.

Keywords

chronic nasopharyngitis, microbiome, bacterial pathogens.


Reference

  1. Schupper AJ, Nation J, Pransky S. Adenoidectomy in Children: What Is the Evidence and What IS its Role? Curr Otorhinolaryngol Rep. 2018;6(1):64-73. doi: 10.1007/s40136-018-0190-8.
  2. Flynn M, Dooley J. The microbiome of the nasopharynx. J Med Microbiol. 2021;70(6):001368.
    doi: 10.1099/jmm.0.001368.
  3. Man WH, Clerc M, de Steenhuijsen Piters WAA, van Houten MA, Chu MLJN, Kool J, et al. Loss of microbial topography between oral and nasopharyngeal microbiota and development of respiratory infections early in life. Am J Respir Crit Care
    Med. 2019;200:760-70. doi: 10.1164/rccm.2 01810-1993OC.
  4. Esposito S, Principi N. Impact of nasopharyngeal microbiota on the development of respiratory tract diseases. Eur J Clin Microbiol Infect Dis. 2018; 37(1):1-7. doi: 10.1007/s10096-017-3076-7.
  5. Dekker A, Verheij T, van der Velden A. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract. 2015;32:401-7. doi: 10.1093/fampra/ cmv019.
  6. Ozkan J, Willcox M, Coroneo M. A comparative analysis of the cephalic microbiome: The ocular, aural, nasal/nasopharyngeal, oral and facial dermal niches. Exp Eye Res. 2022;220:109130. doi: 10.1016/j.exer.2022.109130.
  7. Samarrai R, Frank S, Lum A, Woodis K, Weinstock G, Roberts D. Defining the microbiome of the head and neck: A contemporary review. Am J Otolaryngol. 2022;43(1):103224. doi: 10.1016/j.amjoto.2021.103224.
  8. Dubourg G, Edouard S, Raoult D. Relationship between nasopharyngeal microbiota and patient's susceptibility to viral infection. Expert Rev Anti Infect Ther. 2019;17(6):437-447. doi: 10.1080/14787210.2019.1621168.
  9. Tozzi AE, Del Chierico F, Pandolfi E, Reddel S, Gesualdo F, Gardini S, et al. Nasopharyngeal microbiota in hospitalized children with Bordetella pertussis and Rhinovirus infection. Sci Rep. 2021; 11(1):22858. doi: 10.1038/s41598-021-02322-y.
  10. Ressing ME, van Gent M, Gram AM, Hooykaas MJG, Piersma SJ, Wiertz EJHJ. Immune Evasion by Epstein-Barr Virus. Current Topics in Microbiology and Immunology. 2015;391:355-81. doi: 10.1007/978-3-319-22834-1_12.
  11. Gьnel C, Kırdar S, Цmьrlь İK, Ağdaş F. Detection of the Epstein-Barr virus, Human Bocavirus and novel KI and KU polyomaviruses in adenotonsillar tissues. Int J Pediatr Otorhinolaryngol. 2015; 79(3):423-7. doi:10.1016/j.ijporl.2015.01.007.
  12. Jamiyan T, Nakazato Y, Kuroda H, Kojima M, Imai Y. Characterist ic Histological Findings of Asymptomat ic EBV-associated Lymphoproliferative Disorders in Tonsils. J Clin Exp Hematop. 2018;58(3):122-7. doi: 10.3960/jslrt.18017.
  13. Cleary DW, Clarke SC. The nasopharyngeal microbiome. Emerg Top Life Sci. 2017;1(4):297-312. doi:10.1042/ETLS20170041.
  14. Edouard S, Million M, Bachar D, Dubourg G, Michelle C, Ninove L. et al. The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis. 2018;37(9):1725-33.
    doi: 10.1007/s10096-018-3305-8.
  15. Dubourg G, Edouard S, Raoult D. Relationship between nasopharyngeal microbiota and patient's susceptibility to viral infection. Expert Rev Anti Infect Ther. 2019;17(6):437-47. doi: 10.1080/14787210.2019.1621168.
  16. Chapman TJ, Morris MC, Xu L, Pichichero ME. Nasopharyngeal colonization with pathobionts is associated with susceptibility to respiratory illnesses in young children. PLoS One. 2020;15(12): e0243942. doi: 10.1371/journal.pone.0243942.
  17. Huang CC, Chang TH, Lee CY, Wu PW, Chen CL, Lee TJ. et al. Tissue microbiota in nasopharyngeal adenoid and its association with pneumococcal carriage. Microb Pathog. 2021;157:104999. doi: 10. 1016/j.micpath.2021.104999.
  18. McCauley KE, DeMuri G, Lynch K, Fadrosh DW, Santee C, Nagalingam NN, et al. Moraxelladominated pediatric nasopharyngeal microbiota associate with upper respiratory infection and sinusitis. PLoS One. 2021;16(12):e0261179. doi: 10.1371/ journal.pone.0261179.
  19. Kim SK, Hong SJ, Pak KH, Hong SM. Analysis of the Microbiome in the Adenoids of Korean Children with Otitis Media with Effusion. J Int Adv Otol. 2019;15(3):379-385. doi: 10.5152/iao.2019.6650.
  20. Johnston JJ, Douglas R. Adenotonsillar microbiome: an update. Postgrad Med J. 2018;94(1113):398-403. doi:10.1136/postgradmedj-2018-135602.
  21. Henares D, Brotons P, de Sevilla MF, Fernandez Lopez A, Hernandez-Bou S, Perez-Argьello A, Mira A, Muсoz-Almagro C, Cabrera-Rubio R. Differential nasopharyngeal microbiota composition in children according to respiratory health status. Microb Genom. 2021;7(10):000661. doi: 10.1099/ mgen.0.000661.
  22. Flynn M, Hooper G. Antimicrobial stewardship though FeverPAIN score: Successes and challenges in secondary care. Clin Infect Practice. 2020: 7(10):100024. doi: 10.1016/j.clinpr.2020.100024.
  23. S2k-Leitlinie 017/024: Therapie entzьndlicher Erkrankungen der Gaumenmandeln-Tonsillitis [Therapy of inflammatory diseases of the palatal tonsils – Tonsillitis]. Available from: https://register.awmf.org/de/leitlinien/detail/017-024.
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»